Personalized medicine
Life Length obtains European authorization for its innovative prostate cancer diagnostic ...
PROSTAV® tiene por objeto mejorar sustancialmente el diagnóstico de cáncer de próstata; el más frecuente en los hombres...
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM
The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm...
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM against the ...
The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm...
PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022
PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it...
Venture capital plays key role in fight against cancer
On 28 April, AseBio Investor Day will bring together more than 50 investors from all over the world with disruptive...
Dámaso Molero, CEO of 3P Biopharmaceuticals, appointed member of the Technical Committee o...
Navarra advances in the Comprehensive Strategy for Personalized Medicine with the constitution of the body that will...
Report | The incredible challenge of diagnosing a silent disease: Alzheimer's
To mark World Alzheimer's Day, we spoke to Marta Barrachina, founder and CEO of ADmit Therapeutics, one of our partners...
Personalised medicine increases its activity by 40% in the last year and is becoming more ...
Precision medicine and personalised medicine products or services have gone from representing 12% of total launches to...
Corify Care raises €2.35M to translate its cardiac mapping technology to the market
The investment round is led by Clave Capital, counting with investment from CDTI through its Innvierte program and the...
Algorithms and Image Biomarkers. Radiomics as another piece of precision oncology
Radiomics is revolutionising medical image interpretation